Feasibility of Same-Day Discharge in Patients Undergoing Laparoscopic Gynaecologic Oncology Surgery
To evaluate the safety and feasibility of same-day discharge (SDD) of oncology patients undergoing complex laparoscopic gynaecologic oncology surgery. A retrospective review including patients from October 2019 to July 2023 undergoing surgical staging for endometrial, tubal, or cervical cancer, treatment for endometrial hyperplasia or pelvic masses. Surgeries included a total laparoscopic hysterectomy. Patients accomplishing SDD were compared with those requiring admission. Data collection included clinical, demographic, and perioperative variables up to 6 weeks after surgery. Univariate and multivariate analyses were conducted. A total of 152 patients were included. On multivariate analysis, variables that significantly predicted admission were age ≥61 (OR 0.256; 95% CI 0.102-0.642, P = 0.004), BMI ≥30-34.9 kg/m SDD is safe and feasible for patients. There are few complications, re-admissions, or unscheduled patient contacts postoperatively. Its success can be increased by refining patient selection using predictive variables.